208 related articles for article (PubMed ID: 12644030)
1. Intermittent and on-demand use of proton pump inhibitors in the management of symptomatic gastroesophageal reflux disease.
Bardhan KD
Am J Gastroenterol; 2003 Mar; 98(3 Suppl):S40-8. PubMed ID: 12644030
[TBL] [Abstract][Full Text] [Related]
2. Results of short-and long-term medical treatment of gastroesophageal reflux disease (GERD).
Pohle T; Domschke W
Langenbecks Arch Surg; 2000 Aug; 385(5):317-23. PubMed ID: 11026702
[TBL] [Abstract][Full Text] [Related]
3. Systematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken 'on-demand'.
Pace F; Tonini M; Pallotta S; Molteni P; Porro GB
Aliment Pharmacol Ther; 2007 Jul; 26(2):195-204. PubMed ID: 17593065
[TBL] [Abstract][Full Text] [Related]
4. [Gastroesophageal reflux disease and dyspepsia--drug therapy].
Gräter H
Praxis (Bern 1994); 2006 Aug; 95(31-32):1179-83. PubMed ID: 16909686
[TBL] [Abstract][Full Text] [Related]
5. On-demand therapy is a valid strategy in GERD patients: pros and cons.
Leodolter A; Penagini R
Dig Dis; 2007; 25(3):175-8. PubMed ID: 17827935
[TBL] [Abstract][Full Text] [Related]
6. Treatment of gastroesophageal reflux disease in adults: an individualized approach.
Galmiche JP; Stephenson K
Dig Dis; 2004; 22(2):148-60. PubMed ID: 15383756
[TBL] [Abstract][Full Text] [Related]
7. [Reflux disease: conservative therapy].
Ortner MA
Praxis (Bern 1994); 2002 May; 91(18):791-9. PubMed ID: 12071080
[TBL] [Abstract][Full Text] [Related]
8. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
Armstrong D; Paré P; Pericak D; Pyzyk M;
Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
[TBL] [Abstract][Full Text] [Related]
9. Evolving issues in the management of reflux disease?
Yuan Y; Hunt RH
Curr Opin Gastroenterol; 2009 Jul; 25(4):342-51. PubMed ID: 19417644
[TBL] [Abstract][Full Text] [Related]
10. [Gastroesophageal reflux].
Schwizer W; Fried M
Ther Umsch; 1997 Nov; 54(11):611-6. PubMed ID: 9454361
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis.
Richter JE; Peura D; Benjamin SB; Joelsson B; Whipple J
Arch Intern Med; 2000 Jun; 160(12):1810-6. PubMed ID: 10871975
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan.
Shinozaki S; Osawa H; Kobayashi Y; Sakamoto H; Hayashi Y; Miura Y; Kawarai Lefor A; Yamamoto H
Scand J Gastroenterol; 2018 Aug; 53(8):897-904. PubMed ID: 30056768
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy.
Kawara F; Fujita T; Morita Y; Uda A; Masuda A; Saito M; Ooi M; Ishida T; Kondo Y; Yoshida S; Okuno T; Yano Y; Yoshida M; Kutsumi H; Hayakumo T; Yamashita K; Hirano T; Hirai M; Azuma T
World J Gastroenterol; 2017 Mar; 23(11):2060-2067. PubMed ID: 28373773
[TBL] [Abstract][Full Text] [Related]
14. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
Tolia V; Gilger MA; Barker PN; Illueca M
J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26422096
[TBL] [Abstract][Full Text] [Related]
15. [An evidence-based look at pharmacotherapy for gastroesophageal reflux].
Koop H
Chirurg; 2005 Apr; 76(4):353-8. PubMed ID: 15309265
[TBL] [Abstract][Full Text] [Related]
16. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
Bardhan KD
Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
[TBL] [Abstract][Full Text] [Related]
17. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
Freedberg DE; Kim LS; Yang YX
Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K
Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.
Kinoshita Y; Kato M; Fujishiro M; Masuyama H; Nakata R; Abe H; Kumagai S; Fukushima Y; Okubo Y; Hojo S; Kusano M
J Gastroenterol; 2018 Jul; 53(7):834-844. PubMed ID: 29188387
[TBL] [Abstract][Full Text] [Related]
20. Review article: treatment of mild and severe cases of GERD.
Tytgat GN
Aliment Pharmacol Ther; 2002 Jul; 16 Suppl 4():73-8. PubMed ID: 12047264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
